# Evaluating Microarray Pharmacogenetic Testing in Cancer Patients

> **NCT06489041** · NA · RECRUITING · sponsor: **Wake Forest University Health Sciences** · enrollment: 120 (estimated)

## Conditions studied

- Cancer
- Gastrointestinal Cancer

## Interventions

- **GENETIC:** Pharmacogenomic Testing with the "Global Diversity Array with Enhanced PGx"

## Key facts

- **NCT ID:** NCT06489041
- **Lead sponsor:** Wake Forest University Health Sciences
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2025-07-18
- **Primary completion:** 2026-12
- **Final completion:** 2026-12
- **Target enrollment:** 120 (ESTIMATED)
- **Last updated:** 2026-02-02

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06489041

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06489041, "Evaluating Microarray Pharmacogenetic Testing in Cancer Patients". Retrieved via AI Analytics 2026-07-16 from https://api.ai-analytics.org/clinical/NCT06489041. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*